Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR013106)
Formula Reactant ABT-333 Metabolite M1 Product ABT-333 Metabolite M9
Reactant Info Product Info
Metabolic Enzyme DME Info
Metabolic Type Reduction - Reduction
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013099 ABT-333 ABT-333 Metabolite M1 Oxidation - Oxidation ABT-333 [1], [2]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013110 ABT-333 Metabolite M1 ABT-333 Metabolite M11 Oxidation - Oxidation ABT-333 [1]
MR013108 ABT-333 Metabolite M1 ABT-333 Metabolite M2 Conjugation - Conjugation ABT-333 [1]
MR013105 ABT-333 Metabolite M1 ABT-333 Metabolite M3 Unclear - Unclear ABT-333 [1]
MR013100 ABT-333 Metabolite M1 ABT-333 Metabolite M4 Oxidation - Oxidation ABT-333 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013107 ABT-333 Metabolite M9 ABT-333 Metabolite M10 Unclear - Unclear ABT-333 [1]
References
1 Metabolism and disposition of hepatitis C polymerase inhibitor dasabuvir in humans. Drug Metab Dispos. 2016 Aug;44(8):1139-47.
2 Clinical Pharmacokinetics of Dasabuvir

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.